As of Jun 22
| +1.10 / +1.55%|
The 20 analysts offering 12-month price forecasts for CVS Health Corp have a median target of 89.00, with a high estimate of 100.00 and a low estimate of 68.00. The median estimate represents a +23.30% increase from the last price of 72.18.
The current consensus among 23 polled investment analysts is to Buy stock in CVS Health Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.